A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

• 

• 
  • The Journal
  • Editor-In-Chief
  • Editorial Calendar
  • Submissions
  • Advertising
  • Permissions & Reprints
  • Privacy Policy

• 
  • Subscribe
  • Renew
  • Prices
  • Free Sample

• 
  • View Shopping Cart
  • Back Issues
  • Articles
  • Library Archives
  • Compounding Theme Archives
  • Other Products

• 
  • Supplemental Content and Errata
  • Training and Education
  • IJPC-PCAB SOP Matrix
  • USP GAP Analysis
  • Compounders' Network List
  • Patient Information
  • Videos
  • Compounders' Resource Directory

• 

• 

Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed

Author(s):  Brunner Scott

Issue:  Jul/Aug 2020 - Volume 24, Number 4
View All Articles in Issue

Abstract:  

Related Keywords: Scott Bruner, CAE, U.S. Food and Drug Administration, FDA, memorandum of understanding, interstate distribution, Alliance for Pharmacy Compounding, APC, compounded pain creams, National Academies of Science, Engineering, and Medicine, NASEM, drug combinations, topical preparations, adverse effects, patient-reported outcomes

Related Categories: LEGAL, PROFESSIONAL ISSUES

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details)	Author	Issue	Page	View/Buy
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed	Brunner Scott	Jul/Aug 2020	296-297	Buy
NASEM Report on Compounded Topical Pain Creams	Allen Loyd V Jr	Nov/Dec 2020	446-448	Buy
FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows	Brunner Scott	May/Jun 2021	206-209	Buy
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs	Allen Loyd V Jr	Sep/Oct 2017	356	Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines	Allen Loyd V Jr	Jul/Aug 2016	351	View Sample
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies	Yoch Doug	Mar/Apr 2017	95-102	Buy
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter	Miller David G	May/Jun 2014	208	Buy
The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding	Miller David G	Sep/Oct 2015	375	Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances	Miller David G	Jul/Aug 2015	303-305	Buy
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs	Allen Loyd V Jr	Nov/Dec 2015	487-488	Buy